CABERGOLINE - A LONG-ACTING DOPAMINE AGONIST IN PARKINSONS-DISEASE

被引：30

作者：

LERA, G

VAAMONDE, J

MURUZABAL, J

OBESO, JA

机构：

来源：

ANNALS OF NEUROLOGY | 1990年 / 28卷 / 04期

关键词：

D O I：

10.1002/ana.410280429

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：593 / 594

页数：2

相关论文

共 5 条

[1] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS
FERRARI, C
BARBIERI, C
CALDARA, R
MUCCI, M
CODECASA, F
PARACCHI, A
ROMANO, C
BOGHEN, M
DUBINI, A
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) : 941 - 945
[2] MODIFICATION OF CENTRAL DOPAMINERGIC MECHANISMS BY CONTINUOUS LEVODOPA THERAPY FOR ADVANCED PARKINSONS-DISEASE
MOURADIAN, MM
HEUSER, IJE
BARONTI, F
CHASE, TN
[J]. ANNALS OF NEUROLOGY, 1990, 27 (01) : 18 - 23
[3] CONTINUOUS DOPAMINERGIC STIMULATION IN PARKINSONS-DISEASE
OBESO, JA
LUQUIN, MR
VAAMONDE, J
GRANDAS, F
LAGE, JMM
[J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 488 - 492
[4] STIBE CMH, 1988, LANCET, V1, P403
[5] LEVODOPA CONSUMPTION REDUCES DOPAMINERGIC RECEPTOR RESPONSIVENESS IN PARKINSONS-DISEASE
VAAMONDE, J
LUQUIN, MR
OBESO, JA
[J]. CLINICAL NEUROPHARMACOLOGY, 1989, 12 (04) : 271 - 284